Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress

Vivek K. Gupta*, Yuyi You, Alexander Klistorner, Stuart L. Graham

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    28 Citations (Scopus)

    Abstract

    Tropomyosin-receptor-kinase B (TrkB receptor) activation plays an important role in the survival of retinal ganglion cells (RGCs). This study reports a novel finding that, SH2 domain. -containing phosphatase-2 (Shp-2) binds to the TrkB receptor in RGCs and negatively regulates its activity under glaucomatous stress. This enhanced binding of TrkB and Shp2 is mediated through caveolin. Caveolin 1 and 3 undergo hyper-phosphorylation in RGCs under stress and bind to the Shp2 phosphatase. Shp2 undergoes activation under glaucomatous stress conditions in RGCs in vivo with a concurrent loss of TrkB activity. Inhibiting the Shp2 phosphatase restored TrkB activity in cells exposed to excitotoxic and oxidative stress. Collectively, these findings implicate a molecular basis of Shp2 mediated TrkB deactivation leading to RGC degeneration observed in glaucoma.

    Original languageEnglish
    Pages (from-to)1643-1649
    Number of pages7
    JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
    Volume1822
    Issue number11
    DOIs
    Publication statusPublished - Nov 2012

    Fingerprint

    Dive into the research topics of 'Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress'. Together they form a unique fingerprint.

    Cite this